About Us

Spear Bio is meeting a growing market need for ultrasensitive immunoassays in smaller samples.
Our platform, based on technology licensed from Harvard University, can detect single-digit counts of proteins per sample in minuscule sample volumes.
Our goal is to develop high-impact immunoassays that can be easily adopted by academic and clinical researchers and practitioners.
Our platform has a simple workflow and can be used with existing lab instruments without requiring the purchase of proprietary instruments.
Our Quality Management System is certified ISO 13485:2016

Mission

Delivering precision diagnostics with highly scalable ultrasensitive immunoassays on micro samples

Changing the paradigm of early-stage disease diagnostics and monitoring

Quality Accountability Innovation

Chief Executive Officer
VP & GM, Danaher, VP Abbott, Director Medtronic, P&L, Commercial Leadership, Innovation

Chief Technology Officer & Founder
Inventor of SPEAR Technology
Technology Fellow, Harvard Med/Wyss

Director & Founder
Professor, Harvard Med/Wyss; Inventor of SPEAR Technology, Cofounder of 6 startups

Head of Finance
Wuxi Nextcode, Oxford Immunotec, Philips Medical, 3Com, Merrill Lynch

Head of Human Resources
NeuBase Therapeautics,AvroBio, Decibel Therapeutics, Sarepta, and Toxikon

Sr. Director, Commercial Strategy and Business Development, Marketing and Commercial Leadership at Thermo Fisher, Sensata, and Cabot Corporation

Director of Product Development
Ex-Director, Abcam and Firefly Bioworks
CSO Pathogenica

Head of Production
Co-Inventor of SPEAR Technology
Wyss Institute, Harvard University

Principal R&D Scientist
Fellow Children’s Hospital,
Wyss Institute, Harvard University

Quality Specialist & Document Control
Eurofins, Chemgenes, Toxikon, Syngenta

Address : 100 Tradecenter Dr, Suite 510 , Woburn, MA,01801

"*" indicates required fields